TNF-related death ligand
US6440694B1 · kind B1 · utility
10Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 1998 |
| Grant date | Aug 27, 2002 |
| Priority date | — |
| Expiry date | Sep 21, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to a novel tumor necrosis factor (TNF) homolog designated herein as TNF-related death ligand (TRDL). Isolated nucleic acid molecules are provided which encode TRDL. TRDL polypeptides are also provided, as are methods for identifying agonists and antagonists of TRDL activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.